Physician profile
Ramon Garza
NPI 1750516324
$2,070.92
in general payments reported to CMS, 2019-2025
12 companies · $825 in 2025
The $825 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.72 · 2022: $191 · 2023: $650 · 2024: $379 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $690.56 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Abbvie INC. | $316.13 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $289.31 | 2024-2025 | |
| Rti Surgical, INC | $257.25 | 2025 | |
| Mentor Worldwide LLC | $187.92 | 2023-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Revance Therapeutics, INC. | $139.20 | 2025 | Daxi |
| Stryker Corporation | $67.65 | 2023-2024 | Dermacell, Spy-Phi System |
| Vioptix INC | $47.43 | 2023 | |
| Mannkind Corporation | $28.57 | 2022 | |
| Motiva USA, LLC | $22.18 | 2025 | |
| Tactile Systems Technology INC | $12.43 | 2019 | |
| Baxter Healthcare | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.